Solanbridge Group, Inc. (OTCPK:SLNX) is in the final negotiations to acquire a Colorado health product producer. The negotiations for the acquisition are in their final stages and according to Solanbridge it will have an announcement in the next week or two.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.000001 USD | -.--% | -.--% | -.--% |
2023 | Solanbridge Group, Inc. Reports Earnings Results for the Full Year Ended December 31, 2022 | CI |
2023 | Solanbridge Group, Inc. Auditor Raises 'Going Concern' Doubt | CI |
1st Jan change | Capi. | |
---|---|---|
-.--% | 4.76K | |
-12.79% | 1.45B | |
-23.72% | 1.05B | |
+0.83% | 957M | |
+30.62% | 959M | |
+34.48% | 548M | |
+28.77% | 531M | |
+17.12% | 467M | |
+26.87% | 171M | |
+27.62% | 160M |
- Stock Market
- Equities
- SLNX Stock
- News Solanbridge Group, Inc.
- Solanbridge In Final Negotiations To Acquire Colorado Medical Marijuana Product Producer